According to a market report by Lucintel, the future of the global appendicitis diagnostics and treatment market looks promising with opportunities in the hospital, clinic, and diagnostic imaging center markets. The global appendicitis diagnostics and treatment market is expected to reach an estimated $14 billion by 2030 from $9 billion in 2024 at a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of appendicitis and pediatric appendicitis, growing awareness towards appendicitis, and rising healthcare spending across the globe.
A more
than 150-page report to understand trends, opportunity and forecast in appendicitis
diagnostics and treatment market to 2030 by type (acute and chronic), diagnosis
treatment (diagnosis and treatment), end use (hospitals, clinics, and
diagnostic imaging centers), and region (North America, Europe, Asia Pacific,
and the Rest of the World).
Lucintel
forecasts that acute appendicitis is expected to witness higher growth over the
forecast period as it is characterized by inflammation of the appendix that
develops rapidly, over a period of hours or days.
Within
this market, hospitals & clinics will remain the largest segment.
Download
sample by clicking on appendicitis
diagnostics and treatment market.
North
America will remain the largest region over the forecast period due to high
prevalence of appendicitis and increasing awareness of the disease among
people.
Johnshon
& Johnshon, Pfizer, Lupin, Siemens, Medtronic, Cook, Teva Pharmaceutical
industries are the major suppliers in the appendicitis diagnostics and treatmen market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
3D Printing Medical Device Market
No comments:
Post a Comment